Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2P4LJ5
Fri, 25.06.2021
PharmaSGP Holding SE
PharmaSGP successfully holds first AGM after IPO
2021 Ordinary AGM held virtually due to the pandemic
87.3 % of the share capital was represented
All agenda items approved with clear majorities
Management Board reports on growth prospects based on PharmaSGP platform
Gräfelfing, 25 June 2021 - PharmaSGP Holding SE has successfully held its 2 [ … ]
Tue, 18.05.2021
PharmaSGP Holding SE
PharmaSGP: Expected business development in Q1 2021
Group revenues of € 12.4 million and adjusted EBIT of € 2.0 million impacted by an overall market still significantly burdened by Covid-19
Focus category "Health Brands" and category "Beauty Brands" report revenue developments in line with expectations
Market environment in Q2 remains difficul [ … ]
Wed, 31.03.2021
PharmaSGP Holding SE
PharmaSGP: Revenue growth in 2020 despite declining markets
At €63.2 million, group revenue showed slight growth in a market environment severely impacted by Covid-19
Growth drivers: strategically important 'Health Brands' category grew revenue by 11.8%, International markets showed strong growth with 18.6%
Adjusted EBIT with €16.5 million below [ … ]
Mon, 30.11.2020
PharmaSGP Holding SE
PharmaSGP publishes Q3 Interim Statement 2020
- Group revenues raised by 6.2% to € 48.6 million in the first nine months of 2020; adjusted EBIT margin increased to 31.8%
- Consistent continuation of the growth strategy by expanding the product portfolio and advancing internationalization
- "Health Brands" with +18.2% and foreign markets with +21 [ … ]
Tue, 10.11.2020
PharmaSGP Holding SE
PharmaSGP continues its highly profitable growth course in the third quarter of 2020
- Group revenues grow by 6.2% to € 48.6 million; adjusted EBIT margin increased to 31.8%
- Consistent continuation of growth course by expanding the product portfolio and advancing internationalization
- Foreign markets and "Health Brands" remain key drivers of [ … ]
Wed, 30.09.2020
PharmaSGP Holding SE
PharmaSGP publishes H1 Report 2020 and confirms strong performance and positive outlook for the full year
- Group revenues rise significantly by 7.2% to € 33.8 million in H1 2020, adjusted1 EBIT increases disproportionately by 17.7% to € 10.6 million
- Systematic expansion of the product portfolio and advancing internationalization as key growth [ … ]
Thu, 10.09.2020
PharmaSGP Holding SE
PharmaSGP with strong revenue and EBIT growth and increased profitability in the first half of 2020
- Group revenues rise significantly by 7.2% to € 33.8 million, adjusted EBIT increases disproportionately by 17.7% to € 10.6 million
- Strong revenue development driven mainly by foreign markets and Health Brands
- Consistent expansion of the pro [ … ]
Wed, 02.09.2020
PharmaSGP Holding SE
Sempora market study sees PharmaSGP as the winner in the corona crisis
- PharmaSGP in 1st place by far among almost 50 OTC players in performance comparison of Q1 vs. Q2 2020
- Strategy consultancy Sempora Consulting sees significant competitive advantage for PharmaSGP
- Speed in product launches, flexibility in the marketing approach and a cle [ … ]
Tue, 01.09.2020
PharmaSGP Holding SE
PharmaSGP Holding SE strengthens Management Board for a consistent implementation of its growth strategy
- PharmaSGP to focus even more strongly on internationalization and external growth within its growth strategy
- Maria-Johanna Schaecher to expand the Management Board team as Chief Business Development Officer from mid-September and will take [ … ]